ROYAL BANK OF CANADA - PREVAIL THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$27,000
+200.0%
1,171
+30.1%
0.00%–
Q3 2020$9,000
-35.7%
900
-2.3%
0.00%–
Q2 2020$14,000
+16.7%
921
-5.4%
0.00%–
Q1 2020$12,000
-47.8%
974
-34.6%
0.00%–
Q4 2019$23,000–1,489–0.00%–
 Download
Other shareholders

There were no reported owners of PREVAIL THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of PREVAIL THERAPEUTICS INC shareholders